GO:0000122 [negative regulation of transcription from RNA polymerase II promoter]
GO:0000981 [sequence-specific DNA binding RNA polymerase II transcription factor activity]
GO:0001503 [ossification]
GO:0001649 [osteoblast differentiation]
GO:0001701 [in utero embryonic development]
GO:0001764 [neuron migration]
GO:0001843 [neural tube closure]
GO:0003180 [aortic valve morphogenesis]
GO:0003183 [mitral valve morphogenesis]
GO:0003203 [endocardial cushion morphogenesis]
GO:0003253 [cardiac neural crest cell migration involved in outflow tract morphogenesis]
GO:0003700 [sequence-specific DNA binding transcription factor activity]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0006366 [transcription from RNA polymerase II promoter]
GO:0007517 [muscle organ development]
GO:0008134 [transcription factor binding]
GO:0010628 [positive regulation of gene expression]
GO:0010718 [positive regulation of epithelial to mesenchymal transition]
GO:0014067 [negative regulation of phosphatidylinositol 3-kinase signaling]
GO:0019904 [protein domain specific binding]
GO:0030154 [cell differentiation]
GO:0030326 [embryonic limb morphogenesis]
GO:0030500 [regulation of bone mineralization]
GO:0032000 [positive regulation of fatty acid beta-oxidation]
GO:0032720 [negative regulation of tumor necrosis factor production]
GO:0032760 [positive regulation of tumor necrosis factor production]
GO:0033128 [negative regulation of histone phosphorylation]
GO:0035067 [negative regulation of histone acetylation]
GO:0035115 [embryonic forelimb morphogenesis]
GO:0035116 [embryonic hindlimb morphogenesis]
GO:0035137 [hindlimb morphogenesis]
GO:0035359 [negative regulation of peroxisome proliferator activated receptor signaling pathway]
GO:0042473 [outer ear morphogenesis]
GO:0042476 [odontogenesis]
GO:0042733 [embryonic digit morphogenesis]
GO:0042803 [protein homodimerization activity]
GO:0043066 [negative regulation of apoptotic process]
GO:0043425 [bHLH transcription factor binding]
GO:0043433 [negative regulation of sequence-specific DNA binding transcription factor activity]
GO:0043518 [negative regulation of DNA damage response, signal transduction by p53 class mediator]
GO:0044092 [negative regulation of molecular function]
GO:0045596 [negative regulation of cell differentiation]
GO:0045668 [negative regulation of osteoblast differentiation]
GO:0045766 [positive regulation of angiogenesis]
GO:0045843 [negative regulation of striated muscle tissue development]
GO:0045892 [negative regulation of transcription, DNA-templated]
GO:0045944 [positive regulation of transcription from RNA polymerase II promoter]
GO:0046982 [protein heterodimerization activity]
GO:0046983 [protein dimerization activity]
GO:0048511 [rhythmic process]
GO:0048642 [negative regulation of skeletal muscle tissue development]
GO:0048701 [embryonic cranial skeleton morphogenesis]
GO:0048704 [embryonic skeletal system morphogenesis]
GO:0050679 [positive regulation of epithelial cell proliferation]
GO:0060021 [palate development]
GO:0060348 [bone development]
GO:0060363 [cranial suture morphogenesis]
GO:0060900 [embryonic camera-type eye formation]
GO:0061029 [eyelid development in camera-type eye]
GO:0061309 [cardiac neural crest cell development involved in outflow tract morphogenesis]
GO:0070888 [E-box binding]
GO:0071363 [cellular response to growth factor stimulus]
GO:0071456 [cellular response to hypoxia]
GO:0071639 [positive regulation of monocyte chemotactic protein-1 production]
GO:2000147 [positive regulation of cell motility]
GO:2000276 [negative regulation of oxidative phosphorylation uncoupler activity]
GO:2000679 [positive regulation of transcription regulatory region DNA binding]
GO:2000773 [negative regulation of cellular senescence]
GO:2000778 [positive regulation of interleukin-6 secretion]
GO:2000780 [negative regulation of double-strand break repair]
GO:2000793 [cell proliferation involved in heart valve development]
GO:2000802 [positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation]
